Estimate of the residual risk of transfusion‐transmitted human immunodeficiency virus infection in sub‐Saharan Africa: a multinational collaborative study
Authors:
- Honorine DahourouhHDHonorine Dahourouh
- Alexis E. DokekiasADAlexis E. Dokekias
- Maxime D. KouaoMKMaxime D. Kouao
- Amadou DiarraADAmadou Diarra
- Saliou DiopSDSaliou Diop
- Jean‐Baptiste TapkoJTJean‐Baptiste Tapko
- Edward L. MurphyEMEdward L. Murphy
- Syria LapercheSLSyria Laperche
- Josiane PillonelJPJosiane Pillonel
- 28 September 2010
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 51 (3) , 486-492
Abstract
Sub-Saharan Africa remains the epicenter of the human immunodeficiency virus (HIV) pandemic. However, there is a lack of multicenter data on the risk of transfusion-transmitted HIV from blood centers in sub-Saharan Africa. The incidence of HIV infections in the blood donations collected in the main blood banks of five countries (Burkina Faso, Congo, Ivory Coast, Mali, and Senegal) was determined to estimate the current transfusion risk of HIV infection using the incidence rate/window period model. The risk of transfusion-transmitted HIV infections associated with the window period varied from 1 in 90,200 donations (Senegal) to 1 in 25,600 (Congo). Considering the five participating blood centers as a whole, the incidence rate of HIV-positive donors per 100,000 person-years was 56.6 (95% confidence interval [CI], 47.1-67.9); the residual risk (RR) was 34.1 (95% CI, 7.8-70.7) per 1 million donations, which represents 1 in 29,000 donations (95% CI, 1/128,000-1/14,000). RR estimates varied according to the country. This is potentially due to a lower incidence of HIV infection in the general population or to a more efficient selection of blood donors in the countries with the lowest risk. The estimates of the transfusion risk of HIV infection in each country are important, both to assess the impact of current preventative strategies and to contribute data to policy decisions to reinforce transfusion safety.Keywords
This publication has 29 references indexed in Scilit:
- Reduction of the risk of transfusion‐transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in CameroonTransfusion, 2011
- The risk of transfusion‐transmitted infections in sub‐Saharan AfricaTransfusion, 2010
- Risque résiduel de transmission du VIH et du VHB par transfusion sanguine entre 2003 et 2005 au Centre national de transfusion sanguine de Dakar (Sénégal)Transfusion Clinique et Biologique, 2009
- Census and Analysis of Persistent False-Negative Results in Serological Diagnosis of Human Immunodeficiency Virus Type 1 Group O InfectionsJournal of Clinical Microbiology, 2009
- Characteristics of blood donors and donated blood in sub‐Saharan Francophone AfricaTransfusion, 2009
- Validation, Performance under Field Conditions, and Cost-Effectiveness of Capillus HIV-1/HIV-2 and Determine HIV-1/2 Rapid Human Immunodeficiency Virus Antibody Assays Using Sequential and Parallel Testing Algorithms in TanzaniaJournal of Clinical Microbiology, 2008
- Comparison of Two Rapid Human Immunodeficiency Virus (HIV) Assays, Determine HIV-1/2 and OraQuick Advance Rapid HIV-1/2, for Detection of Recent HIV SeroconversionJournal of Clinical Microbiology, 2008
- HIV Type 1 Subtypes among STI Patients in Nairobi: A Genotypic Study Based on Partial pol Gene SequencingAIDS Research and Human Retroviruses, 2006
- Hemovigilance in Countries with Scarce Resources –A WHO PerspectiveTransfusion Alternatives in Transfusion Medicine, 2003
- Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsTransfusion, 1995